指南与共识乳腺乳腺X线MR

ACR适用性标准® 女性乳腺癌筛查:2023年更新

ACR Appropriateness Criteria® Female Breast Cancer Screening: 2023 Update.
指南 / 共识 · J Am Coll Radiol · 2024-01-01

该指南由美国放射学会基于证据制定,采用GRADE等方法评估文献,按平均、中等和高风险分层给出筛查建议:所有风险类别均推荐乳腺X线摄影和数字乳腺断层合成,高风险患者 additionally 推荐乳腺MRI筛查。

要点

  • 所有风险类别的女性均推荐乳腺X线摄影和数字乳腺断层合成进行筛查。
  • 高风险患者除乳腺X线摄影和数字乳腺断层合成外,还推荐乳腺MRI筛查。
  • 筛查建议基于个体乳腺癌风险分层(平均、中等和高风险)制定。

核心结论

  • 对于出生时指定为女性且具有原生乳腺组织者,所有风险类别均推荐乳腺X线摄影和数字乳腺断层合成筛查;高风险患者还推荐乳腺MRI筛查。

研究设计与样本

  • 美国放射学会适用性标准,由多学科专家小组每年审查,采用GRADE等方法系统分析同行评议文献,并使用RAND/UCLA适用性方法确定影像检查的适用性。

诊断标准与关键数值

  • 所有风险类别均推荐乳腺X线摄影和数字乳腺断层合成作为乳腺癌筛查方法。
  • 高风险患者除乳腺X线摄影和数字乳腺断层合成外,还推荐乳腺MRI筛查。

局限性

  • 在同行评议文献缺乏或模棱两可的情况下,专家可能是制定建议的主要证据来源。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Early detection of breast cancer from regular screening substantially reduces breast cancer mortality and morbidity. Multiple different imaging modalities may be used to screen for breast cancer. Screening recommendations differ based on an individual's risk of developing breast cancer. Numerous factors contribute to breast cancer risk, which is frequently divided into three major categories: average, intermediate, and high risk. For patients assigned female at birth with native breast tissue, mammography and digital breast tomosynthesis are the recommended method for breast cancer screening in all risk categories. In addition to the recommendation of mammography and digital breast tomosynthesis in high-risk patients, screening with breast MRI is recommended. The American College of Radiology Appropriateness Criteria are evidence-based guidelines for specific clinical conditions that are reviewed annually by a multidisciplinary expert panel. The guideline development and revision process support the systematic analysis of the medical literature from peer reviewed journals. Established methodology principles such as Grading of Recommendations Assessment, Development, and Evaluation or GRADE are adapted to evaluate the evidence. The RAND/UCLA Appropriateness Method User Manual provides the methodology to determine the appropriateness of imaging and treatment procedures for specific clinical scenarios. In those instances where peer reviewed literature is lacking or equivocal, experts may be the primary evidentiary source available to formulate a recommendation.

来源:J Am Coll Radiol,查看原文。版权归原作者所有。

引用

  1. Niell BL, Jochelson MS, Amir T, et al. ACR Appropriateness Criteria® Female Breast Cancer Screening: 2023 Update. J Am Coll Radiol. 2024. PMID: 38823941. doi:10.1016/j.jacr.2024.02.019

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。